Medical Claims Data
China: Key Considerations in Using Real-World Evidence to Support Drug Development – A compilation of information on medical claims submitted to insurance companies for access to claims for treatments and other interventions (as per Key Considerations in Using Real-World Evidence to Support Drug Development (Draft for Public Review) – Center for Drug Evaluation, NMPA – May, 2019)
« Back to Glossary Index